To make everything on a bioprocessing line—from development and materials through production to testing and analytics—run as a digitally managed system, all platforms must be integrated and controlled with automation and software.
Patients with a rare inherited disease affecting their sight experienced quick vision improvements that sustained for a year.
Understanding age-and sex-related differences in melanoma will provide insights that may help lead to the development of personalized therapies.
Symbiotic Capital launches with $600 million-plus in capital, about half of which has been lent to advanced-stage life sciences companies.
Lentiviral vectors (LVVs) are becoming increasingly prominent in the advanced therapy space, according to Rentschler Biopharma.
The scientist will focus on brain repair as a model system, with the ultimate goal of harnessing microglial states.
Radiopharmaceuticals work like radiotherapy but provide localized—rather than external—delivery of a radioisotope.
A team of researchers concluded that multivariate data analysis can be applied to large data sets to enable deep learning.
Controlling a biopharmaceutical continuous process is a conceptual shift for an industry built on batch-mode manufacturing.
Recent growth in the heterogeneity of the biotech pipeline has increased demand for microbial manufacturing capacity.
KromaTiD reports that the dGH platform, a cytogenomics-based technology, can detect gene editing–associated structural variants at high resolution on a cell-by- cell basis.
